Our Sustainability Report is prepared annually in accordance with the Global Reporting Initiative (GRI-G4 – Sustainability Reporting Guidelines), with external verification performed by an independent auditor. We were the first national pharmaceutical company to use the GRI-G4 methodology, the international standard most widely used by organizations worldwide for sustainability reporting.
Since 2006, we have publicly presented our financial results and a summary of our annual actions. In 2009, we were the first Brazilian pharmaceutical laboratory to adopt the GRI Standards international methodology of the Global Reporting Initiative.
We used consultations with our main stakeholders to guide the content to be reported in this report, which indicated the topics they considered important to see portrayed. We also considered our strategic planning with Vision 2022 and the trends and challenges of the pharmaceutical industry.
The 2020 Report for the period from January 1 to December 31, 2019 presents a direct report based on data related to topics that are relevant to society, the employees and the market.
If you are interested in accessing the report content, simply fill out the form at the bottom of the page.
Fill out the following form to request access to the Reports. You will receive a token by email, which will be your access key to the report content.